Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: Results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis, 9th Ed: American college of chest physicians evidence-based clinical practice guidelines

dc.contributor.authorKristiansen, Annette
dc.contributor.authorBrandt, Linn
dc.contributor.authorAgoritsas, Thomas
dc.contributor.authorAkl, Elie A.
dc.contributor.authorBerge, Eivind
dc.contributor.authorJacobsen, Anne Flem
dc.contributor.authorGranan, Lars Petter
dc.contributor.authorHalvorsen, Sigrun
dc.contributor.authorGordon, Guyatt H.
dc.contributor.authorVandvik, Per Olav
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:42:50Z
dc.date.available2025-01-24T11:42:50Z
dc.date.issued2014
dc.description.abstractBACKGROUND: The Antithrombotic Therapy and the Prevention of Thrombosis, 9th Edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (AT9) represent trustworthy international guidelines for antithrombotic treatment and thromboprophylaxis. We describe major changes to the format and content resulting from applying new strategies for guideline adaptation and dissemination.; RESULTS: We applied a novel presentation format to 333 recommendations from 11 of the 15 management chapters in AT9 and condensed and restructured them into 249 recommendations in a multilayered format. We added additional relevant information, such as 29 bestpractice statements about new oral anticoagulants and practical information sections for 121 recommendations. Common reasons for modifications included feasibility of the recommendations in a national context, disagreement with applied baseline risk estimates, and reevaluation of the balance between the benefits and harms of interventions in relation to assumed typical patient preferences and values. The adapted guideline was published and disseminated online in November 2013.; METHODS: A Norwegian guideline panel of 46 experts completed a structured and systematic adaptation process, updated the recommendations based on new evidence, and rewrote the recommendations in an electronic multilayered presentation format. We published the adapted guideline using the web-based Making GRADE the Irresistible Choice Guideline Authoring and Publication Platform.; CONCLUSIONS: New strategies for adapting, updating, and disseminating trustworthy guidelines proved feasible and will provide Norwegian health-care professionals and patients with up-to-date guidance tailored to national circumstances. © 2014 AMERICAN COLLEGE OF CHEST PHYSICIANS.
dc.identifier.doihttps://doi.org/10.1378/chest.13-2993
dc.identifier.eid2-s2.0-84907200783
dc.identifier.pmid25180724
dc.identifier.urihttp://hdl.handle.net/10938/30096
dc.language.isoen
dc.publisherAmerican College of Chest Physicians
dc.relation.ispartofChest
dc.sourceScopus
dc.subjectEvidence-based medicine
dc.subjectFeasibility studies
dc.subjectFibrinolytic agents
dc.subjectHumans
dc.subjectPractice guidelines as topic
dc.subjectReproducibility of results
dc.subjectRisk factors
dc.subjectThrombosis
dc.subjectAcetylsalicylic acid
dc.subjectAnticoagulant agent
dc.subjectApixaban
dc.subjectClopidogrel
dc.subjectDabigatran
dc.subjectDipyridamole
dc.subjectFondaparinux
dc.subjectLow molecular weight heparin
dc.subjectPrasugrel
dc.subjectRivaroxaban
dc.subjectTicagrelor
dc.subjectWarfarin
dc.subjectFibrinolytic agent
dc.subjectAdaptation
dc.subjectArticle
dc.subjectDeep vein thrombosis
dc.subjectEthnic group
dc.subjectEvidence based practice
dc.subjectHealth care personnel
dc.subjectHeparin induced thrombocytopenia
dc.subjectHuman
dc.subjectIncidence
dc.subjectInformation dissemination
dc.subjectNorway
dc.subjectNorwegian
dc.subjectPatient preference
dc.subjectPoint of care testing
dc.subjectPractice guideline
dc.subjectPrevalence
dc.subjectRisk benefit analysis
dc.subjectEvaluation study
dc.subjectEvidence based medicine
dc.subjectFeasibility study
dc.subjectProcedures
dc.subjectReproducibility
dc.subjectRisk factor
dc.subjectStandards
dc.titleApplying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: Results from the Norwegian adaptation of the antithrombotic therapy and the prevention of thrombosis, 9th Ed: American college of chest physicians evidence-based clinical practice guidelines
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2014-10584.pdf
Size:
453.48 KB
Format:
Adobe Portable Document Format